In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 343 for your search:
Drug:  daunorubicin hydrochloride
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 15 to 65
Sponsor: Other
Protocol IDs: GMALL03, NCT00199004
2.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 60 and over
Sponsor: Other
Protocol IDs: AML_GT60_DD, NCT00180167
3.

Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 65 and under
Sponsor: Other
Protocol IDs: AML99<=65 años, NCT00390715
4.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 15 and over
Sponsor: Other
Protocol IDs: LAL-RI/96, NCT00494897
5.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 65 and under
Sponsor: Other
Protocol IDs: LAL-Ph-2000, NCT00526305
6.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 15 to 65
Sponsor: Other
Protocol IDs: GMALL04, NCT00199017
7.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 60 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PDL-3-251, MSKCC-93131, NCI-V94-0469
8.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: under 18
Sponsor:
Protocol IDs: SJCRH-ALL-TT-8
9.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: under 60
Sponsor:
Protocol IDs: NCI-D81-018-590, DFCI-80035
10.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: NCI-D82-051-605
11.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: under 21
Sponsor: NCI
Protocol IDs: CCG-192P
12.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 1 to 20
Sponsor: NCI
Protocol IDs: POG-8698
13.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: under 21
Sponsor: NCI
Protocol IDs: SJCRH-AML-87, NCI-T86-0203D, T86-0203
14.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 21 and under
Sponsor: NCI
Protocol IDs: POG-8862
15.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: under 20
Sponsor:
Protocol IDs: ARG-GATLA-1LLAREC90, NCI-F92-0006, NCT00002499
16.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 16 to 50
Sponsor: Other
Protocol IDs: HORCSCT-0903, NCT01015261
17.

Phase: Phase III
Type: Treatment
Status: Closed
Age: under 17
Sponsor:
Protocol IDs: GER-GPOH-AML-BFM-93, EU-93008
18.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 15 to 60
Sponsor: Other
Protocol IDs: CDR0000063311, EORTC-06931, NCT00002549
19.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 1 to 21 at diagnosis
Sponsor: NCI
Protocol IDs: POG-9406, POG-ALINC-16/HR
20.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 56 and over
Sponsor: NCI
Protocol IDs: SWOG-9333
21.

Phase: Phase III
Type: Treatment
Status: Closed
Age: under 21
Sponsor: NCI
Protocol IDs: POG-9421
22.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 15 to physiologic 59
Sponsor: Other
Protocol IDs: MRC-LEUK-AML12, EU-95001, NCT00002658
23.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 15 to 60
Sponsor: Other
Protocol IDs: CDR0000064498, EORTC-06951, FRE-LALA-94, NCT00002700
24.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 1 to 9
Sponsor: NCI
Protocol IDs: CCG-1952, NCT00002744
25.

Phase: Phase III
Type: Treatment
Status: Closed
Age: over 1 and under 15
Sponsor:
Protocol IDs: MRC-LEUK-UKALL-XI, EU-95036
1     
New Search